FDA approves quick malaria test

Jun 27, 2007

The U.S. Food and Drug Administration has approved the Binax NOW Malaria Test, the first rapid test authorized for laboratory use in the United States.

Standard laboratory tests for malaria require identifying parasites in a blood sample under a microscope -- a difficult task requiring training and experience.

The FDA said the new test is significantly faster and easier to use, producing results in 15 minutes after a few drops of whole blood are placed on a dipstick.

The test can also differentiate the most dangerous malaria parasite, Plasmodium falciparum, from less virulent malaria parasites. Results, however, still need to be confirmed using standard microscopic evaluation, the FDA noted.

Malaria was eliminated in the United States during the 1950s but citizens can become infected while traveling in other countries. There were 1,528 new U.S. cases of malaria reported during 2005, including seven deaths. The FDA said nearly all deaths can be prevented if the infection is diagnosed and treated early.

FDA scientists found the Binax NOW test was 95 percent accurate compared with standard microscopic diagnosis in a multi-center study.

The test is manufactured by Binax Inc., a subsidiary of Inverness Medical Innovations Inc.

Copyright 2007 by United Press International

Explore further: Clinical trial of Auxilium's Xiaflex shows it to be effective in smoothing cellulite

add to favorites email to friend print save as pdf

Related Stories

Non-human sugar in biotech drugs causes inflammation

Jul 25, 2010

Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response ...

Recommended for you

Using computers to design drugs

23 hours ago

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

New US restrictions on painkiller to take effect

Aug 21, 2014

The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.

User comments : 0